Amit Kakar M.D.

Amit Kakar MD is a seasoned professional in the fields of healthcare investment and management, currently serving as Managing Partner and Head of Novo Holdings Asia since August 2020. At Novo Holdings, a company under the Novo Nordisk Foundation, Amit oversees investment strategies while also actively participating on the Evaluation Committee for DxD Hub and as Chairman of the Board for MedGenome, a leading genomics platform. Additional board roles include positions at Qure.ai, Doctor Anywhere, and Esco. Previous experience includes leadership in mergers and acquisitions at Everlife Asia, as well as board member roles at Hubei Laobaixing Pharmacy Chain Co., Ltd., Clinical Innovations, and Theraclion. Amit's educational background includes degrees in medicine and management from prestigious institutions.